# Q2B Validation of Analytical Procedures: Methodology - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q2b-validation-of-analytical-procedures-methodology/582c54c8-1b4b-41ac-9986-b492b25f4794

> FDA guidance document: Q2B Validation of Analytical Procedures: Methodology. Issue date: May 19, 1997. Get complete insights and analysis.

---

## Details

- Title: Q2B Validation of Analytical Procedures: Methodology
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1997-05-19
- Last Changed: 2020-04-14
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-1996-D-0169">FDA-1996-D-0169</a>

## Related Documents

- [S1B Testing for Carcinogenicity of Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s1b-testing-for-carcinogenicity-of-pharmaceuticals/8cc92fb9-6b17-465b-8cf3-ba1e865720dd)
- [Q1B Photostability Testing of New Drug Substances and Products](https://www.globalkeysolutions.net/guidances/guidance-document/q1b-photostability-testing-of-new-drug-substances-and-products/e6b04732-10d6-4998-b8d0-6dff64f41474)
- [S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/s6-preclinical-safety-evaluation-of-biotechnology-derived-pharmaceuticals/b4092e3c-509e-4d7e-9f1c-4d7274985cc7)